Actively Recruiting
Advanta VXT and Flixene PMCF Registry
Led by Atrium Medical Corporation · Updated on 2026-03-13
1000
Participants Needed
2
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.
CONDITIONS
Official Title
Advanta VXT and Flixene PMCF Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to provide legally effective written informed consent as required by IRB/EC
- Male and female patients who have undergone replacement or repair of peripheral arteries using the Advanta VXT or Flixene vascular graft
- At least 18 years old at the time of the procedure
- Available medical records with a minimum of 36 months of follow-up data
You will not qualify if you...
- Active infection in the region of graft placement at the time of implantation of the Advanta VXT or Flixene vascular graft
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
2
CHU de Brest
Brest, Brittany Region, France
Actively Recruiting
Research Team
S
Senior Manager, Clinical Affairs
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here